Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

21:53 EST 3rd March 2015 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 22,000+

Tuesday 3rd March 2015

Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference

SAN DIEGO, March 3, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Barclays 2015 Global Healthcare Conference in Miami, FL on March 10, 2015 at 1:05 p.m. ET/10:05 a.m. PT. David A. Ramsay, Chief Financial Officer, will provide a corporate overview. The presentation will be webcast through the "Investors" section of Halozyme's corporate website at ww...

Vermillion To Present at 27th Annual ROTH Conference on March 9

AUSTIN, Texas, March 3, 2015 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced management will present at the 27th Annual ROTH Conference, which is being held at the Ritz-Carlton in Dana Point, California from March 8 to March 11. President and CEO of Vermillion, Valerie Palmieri, will be presenting on Monday,...

New Projects for Image Interpretation and Management in Clinical Trials Totaling €1.53M for MEDIAN Technologies

New projects awarded* for the interpretation and management of medical images: a phase I study for solid tumor cancers and a phase II study for prostate cancer. Contract extension for a phase I/II study for solid tumor cancers. Regulatory News: MEDIAN Technologies (Paris:ALMDT), a leading medical imaging solu...

Tina’s Wish to Honor President Bill Clinton with Inaugural Global Women’s Health Award

Nonprofit that funds research for early detection of ovarian cancer awards Founder of the Clinton Foundation for supporting the cause of women's health globally New York, NY (PRWEB) March 03, 2015 Tina’s Wish, the only nonprofit organization dedicated exclusively to funding research for the early detection of ovarian cancer, announced today that it will honor President Bill Clinton with the...

Seeds Top EBRT as Boost Tx in Prostate Cancer

(MedPage Today) -- And other advances in prostate cancer care from the Genitourinary Cancers Symposium.

GymLynx Launches New Online Fitness Marketplace

Independent fitness trainers and instructors can now browse, compare and rent indoor workout space GymLynx, Inc., a new and exciting addition to the online fitness industry, today announced the launch of its online marketplace to offer independent fitness trainers, instructors, coaches and specialists the ability to easily browse fitness facilities in ...

Consumerism Driving Big Changes to Patient Collection Practices for Providers

Availity study reveals gap between provider awareness and related collection practices While 85 percent of providers agree that patient financial responsibility is increasing, and 90 percent believe collecting from patients before they leave the office is important, less than 35 percent of patient-owed dollars are being collected up front. This is acco...

IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership

The OncLive® and IU Simon Cancer Center alliance facilitates sharing news about the center’s research and education programs and accomplishments. PLAINSBORO, N.J. (PRWEB) March 03, 2015 OncLive® and Indiana University Melvin and Bren Simon Cancer Center have joined forces to share news about the center’s research and education programs, OncLive announced today. The collaboration is ...

Expectant Couples Worldwide Can Now Receive Training and Education in Natural Childbirth and Breastfeeding from Birth Boot Camp

The natural childbirth education company now has more than 130 certified instructors in over 30 states as well as a 10-week online childbirth education course with more than 20 hours of streaming video. Birth Boot Camp also certifies childbirth educators and recently launched a new doula certification program. Mansfield, Texas (PRWEB) March 03, 2015 Birth Boot Camp, a company specializing in natu...

Study shows testosterone being prescribed when not medically needed

A new study by the University of Texas Medical Branch found that 20 percent of men were prescribed testosterone despite having normal testosterone levels based on the Endocrine Society's guidelines. The study also found that 39 percent of new testost...

Brain Protein Tied to Alzheimer's Spotted in Young Adults

MONDAY, March 2, 2015 -- Brain plaque buildup, long linked to the onset of Alzheimer's disease, has been identified in the brains of men and women as young as 20, researchers say. "One thing this means is that the resource, the machinery, for...

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

Colin Cooper and colleagues report genome-wide sequences of multiple samples of multifocal cancer and morphologically normal tissue from the prostates of three men. They found high levels of mutations in morphologically normal tissue distant from the...

New Medical Oncologist Joins Virginia Cancer Specialists, Enhancing Expertise and Access to Advanced Cancer Care Services

Mitul Gandhi, M.D., complements the VCS world-class care team, broadening expertise in lymphoma Virginia Cancer Specialists (VCS), Virginia’s premier cancer care center with 40 years of service to patients battling cancer and blood diseases, has added a new medical oncologist to the practice.

Jolen, A Brand Trusted by Women for Over 50 Years, Introduces Jolen Facial Hair Remover Kit

Women have trusted the Jolen brand to deliver superior results in bleaching facial hair for over 50 years, making it the #1 bleach in the world. Now Jolen is using its expertise to introduce the new Jolen Facial Hair Remover Kit, a unique three-part system that provides gentle, effective facial hair removal with a pleasant scent and no irritation. NEW YORK, NY (PRWEB) March 03, 2015 Women have tr...

Twelve Months Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to Be Presented at ENDO 2015 Conference

OPKO Health, Inc. (NYSE: OPK), today announced the presentation of two posters at the 97th Annual Meeting of the Endocrine Society (ENDO) on March 5th, 2015 in San Diego, California, that will include twelve months data from OPKO’s advanced phase 2 trial for its long acting human growth hormone hGH-CTP in growth hormone deficient pediatric subjects. ...

Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices

Women’s Health Expert to Discuss On-Demand Access to Specialty Clinical Expertise for Underserved Patient Communities MINNEAPOLIS, MN — (PRWEB) March 03, 2015 -- vRad (Virtual Radiologic), the nation’s largest telemedicine company and radiology practice, today announced that Arlene Sussman, MD, a highly regarded breast imaging and breast health expert, will host a live webinar to explore how...

FDA Grants Orphan Drug Designation to Oncolytics BIotech's Primary Peritoneal Cancer

Oncolytics Biotech Inc. ("Oncolytics"), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, Reolysin, for the treatment of primary peritoneal cancers.

FDA Grants Orphan Drug Designation to Oncolytics' Cancer Treatment

Oncolytics Biotech Inc. ("Oncolytics"), a clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for its lead product candidate, Reolysin, for the treatment of primary peritoneal cancers.Read more

Amgen says a study found its cancer drug more effective than rival drug

Amgen Inc., the Thousand Oaks, Calif., biotech giant, said Sunday a new study has found its cancer drug Kyprolis is far more effective in treatment of relapsed multiple myeloma than its chief rival.

Goody’s®, PediaCare® and Little Remedies® Launch Interactive Consumer Loyalty Program

Consumers Can Earn Rewards for Simply Engaging with These Top Healthcare Brands That They Already Love Prestige Brands, Inc., the parent company of Goody’s® Powder, PediaCare® and Little Remedies®, has launched an innovative online rewards program for consumers of these healthcare brands. The program will allow customers to earn points towards exc...

Bostonians Rank Nine Area Hospitals: Mass General on Top Followed by Brigham and Women’s, Beth Israel Deaconess

Even in a crowded hospital market dominated by well-known and highly regarded research institutions, Massachusetts General Hospital stands out from its local competition. Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center score well on consideration and impression, resulting in second- and third-place rankings, respectively. These and ...

Losing weight before pregnancy is healthier for mom, baby

Before she got pregnant in 2014, Lizzy King, 28, of East Lansing, Mich., gave herself a "lifestyle overhaul." She started running and lost 50 pounds. She eschewed processed food and ate her first banana.

Arthritis Foundation Honors 2015 "Women On The Move"

NEW YORK, March 3, 2015 /PRNewswire-USNewswire/ -- The Arthritis Foundation is honoring three women of achievement as this year's  "Women on the Move" for their support of the organization's mission to raise awareness and find a cure for arthritis, a disease which affects one in five adults and 300,000 children. The 2015 Women on the Move honorees are: Lori Epstein, JD, Vice President, Adva...

Clinical Trial Comparing the Surefire Infusion Device to an End Hole Catheter Finds Surefire Increases Tumor Uptake and Decreases Non-Target Embolization In Every Patient, Multiple Liver Cancer Types

ATLANTA, March 3, 2015 /PRNewswire/ -- Surefire Medical, Inc. today announced the results of a prospective clinical trial comparing the Surefire Infusion System with an end hole microcatheter.  In patients with either primary or metastatic liver cancer, using the Surefire resulted in statistically significant increases in tumor uptake of embolic agents, and with significantly decrea...

Cancer Cachexia Therapeutics Pipeline Drugs and Companies Review H1 2015 Research Report

DALLAS, March 3, 2015 /PRNewswire/ -- ReportsnReports.com offers Cancer Cachexia - Pipeline Review, H1 2015 research report that provides an overview of the Cancer Cachexia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cancer Cachexia. Cancer Anorexia-Cachexia Syndrome is a multifactorial syndrome that negatively impacts the functional ...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks